维普期刊资源整合服务平台（V6.5）

27篇 您的检索式：作者名="Bugat R"

选中清除导出查看参考文献查看引证文献引用追踪共2页首页上一页第1页下一页末页 /2 跳转

	题名	作者	年代	出处	被引量
1	Phase Ⅱ study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy显示文摘	Rougier P Bugat R Douillard JY	1997	J Clin Oncol1997，15，1：	1
2	Irinotecan in the treatment of gastric cancer显示文摘	Bugat R		0，，2：	1
3	Irinotecan in the treatment of gastric cancer显示文摘	Bugat R	2003	Ann Oncol2003，14，2：	1
4	Multimodal therapy with intrave- nous biweekly leucovorin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer显示文摘	Zelck L Bugat R Cherqui D	2003	Ann Onco12003，14，10：	1
5	Vinorelbine-related cardiac events: a meta-analysis of randomized clinical trials显示文摘	Lapeyre-Mestre M Gregoire N Bugat R	2004	Fundam Clin Pharmacol2004，18，：	1
6	Irinotecan in the treatment of gastric cancer显示文摘	Bugat R	2003	AnnOncol2003，142，：	1
7	Irinotecan in the treatment of gastric cancer 显示文摘	Bugat R	2003	Annals of Oncology2003，14，2：	1
8	Vinorelbine-related cardiac events: a meta-analysis of randomized clinical trial 显示文摘	Lapeyre-Mestre M Gregoire N Bugat R	2004	Fundam Clin Pharmaco12004，18，1：	1
9	Phase Ⅱ study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy-naive patients and patients pretreated with fluorouracil-based chemotherapy显示文摘	Rougier P Bugat R Douillard JY	1997	J Clin Oncol1997，15，1：	1
10	Summary of the standards, options and recommendations for the management of patients with carcinoma of unknown primary site显示文摘	Bugat R Bataillard A Lesimple T	2003	Br J Cancer2003，，：	1
11	Irinotecan in combination with CDDP or 5-FU and folinic acid is active in patients with advanced gastric or gastro-oesophageal junction adenocarcinoma:Final results of a randomized phase II study显示文摘	Pazzo C Bugat R Peschel C		Proc Am Soc Clin Oncol0，2，：	1
12	Phase II study of irinote- can in the treatment of advanced colorectal cancer in chemotherapy- naive patients and patients pretreated with fluorouracil-based chemotherapy 显示文摘	Rougier P Bugat R Douillard JY	1997	J Clin Oneol1997，15，1：	1
13	Irinotecan in the treatment of gastric cancer显示文摘	Bugat R	2003	Ann oncol2003，14，2：	1
14	Summary of the Standards Options and Recommendations for the management of patients with carcinoma of unknown primary site (2002)显示文摘	Bugat R Bataillard A Lesimple T	2003	Br J Cancer2003，89，1：	1
15	Irinoteean in the treatment of gastric cancer显示文摘	Bugat R	2003	Ann Oneol2003，14，2：	1
16	Phase II study of irinotecan in the treatment of advanced colorectal cancer in chemotherapy - naive patients and patients pretreated with fluorouracil - basedc hemotherapy 显示文摘	Rougier P Bugat R Douillard JY	1997	J Clin Oncol1997，15，：	1
17	Irinotecan in the treatment of gastric cancer显示文摘	Bugat R	2003	Ann Oncol2003，14，2：	1
18	Phase 1 and pharmacokinetic study of camptothecin derivative irinotecan, administered on a weekly schedule in cancer patients显示文摘	De Fomi M Bugat R Chabot G	1999	Cancer Res1999，15，：	1
19	Multimodal therapy with intra- venous biweekly leucovofin, 5-fluorouracil and irinotecan combined with hepatic arterial infusion pirarubicin in non-resectable hepatic metastases from colorectal cancer (a European Association for Re- search in Oncology trial)显示文摘	Zelek L Bugat R Cherqui D	2003	Ann Oncol2003，14，10：	1
20	Summary of the standards, options and recommendations for the management of patients with carci- noma of unknown primary site 显示文摘	Bugat R Bataillard A Lesimple T	2003	Br J Cancer2003，89，1：	1

返回顶部每页显示：

共2页首页上一页第1页下一页末页 /2 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示